Pfizer acquires US biologics manufacturing plantJanuary 17, 2023 - Pfizer "inked a deal to acquire Abzena’s manufacturing plant, which boasts “extensive capabilities” for the production of biologics drug substance, the companies announced on Tuesday."
“Biologics continue to be an integral part of Pfizer’s pipeline and this acquisition will expand our research, clinical and commercial manufacturing capacity and help us accelerate the development of our pipeline products as well as support our Pfizer CentreOne customers,” said Pfizer’s executive VP and chief global supply officer Mike McDermott said in the release. Abzena and Pfizer’s CentreOne contract manufacturing unit will collaborate on biologics going forward, the companies said.
The Sanford facility was Abzena’s only site in North Carolina, though the San Diego-based company lists other locations in California, Pennsylvania and the UK.
The new facility is near Pfizer’s existing Rocky Mount and Sanford manufacturing sites, McDermott noted
https://endpts.com/pfizer-inks-deal-to-snatch-abzenas-new-north-carolina-manufacturing-site/